Latest revenue
$309.9M
as of 2026-03-31
Latest net income
$11.4M
as of 2026-03-31
Net margin
3.7%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $2.02B
- Enterprise value
- $2.02B
- P/E (trailing)
- 984.3×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $55.00
- 52-wk low
- $26.84
- Beta
- —
- Shares out
- 45.5M
5-year trend
What this company does
ITEM 1. BUSINESS Overview Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, is committed to solving the critical challenges inherent in medication management and elevating the role of clinicians within healthcare as an essential component of care delivery. Omnicell is focused on helping its customers define and deliver a cost-effective medication management strategy designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. We are doing this with an industry-leading medication management…
AI summary unavailable — showing raw filing excerpt
Generated from OMCL's filing dated 2026-02-26
Key risks
ITEM 1A. RISK FACTORS Summary of Risk Factors An investment in our company involves various risks. The following is a summary of these risks, but does not address all of the risks that we face. Additional discussion of the risks that we face can be found following this summary and should be carefully considered together with all of the other information appearing in this Annual Report on Form 10-K. Risk Factors Related to our Business and Industry •Economic Conditions and Demand Risks. Weak or uncertain economic conditions may adversely impact our business, as well as any reduction in demand for, or adoption or installation of Omnicell’s medication management solutions, medication packaging…
AI summary unavailable — showing raw filing excerpt
Generated from OMCL's filing dated 2026-02-26
Profitability
Gross margin
42.5%
0.3%Operating margin
0.4%
1337.3%Net margin
0.2%
84.6%Return on equity
0.2%
83.5%Return on assets
0.1%
82.4%Leverage
Debt / equity
0.60×
14.6%Long-term debt / equity
0.14×
1.7%Debt / assets
37.6%
9.1%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $309.9M | +14.9% | $11.4M | +261.7% | 3.7% |
Q4 2025 2025-12-31 | $314.0M | +2.3% | $6.4M | -77.0% | 2.0% |
Q3 2025 2025-09-30 | $310.6M | +10.0% | $4.1M | +223.2% | 1.3% |
Q2 2025 2025-06-30 | $290.6M | +5.0% | $-1.4M | -137.1% | -0.5% |
Q1 2025 2025-03-31 | $269.7M | +9.6% | $-7.0M | +55.2% | -2.6% |
Q4 2024 2024-12-31 | $306.9M | — | $27.8M | — | 9.1% |
Q3 2024 2024-09-30 | $282.4M | -5.4% | $-3.3M | -159.6% | -1.2% |
Q2 2024 2024-06-30 | $276.8M | -7.4% | $3.7M | +8.2% | 1.3% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Electronic Computers · SIC 3571
Your notes
Keep private notes on OMCL — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$2.6M
Net activity
−$2.6M
Distinct insiders
3
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns OMCL
Institutional value
$794.7M
Total shares held
24.3M
Distinct holders
159
-102 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 7.2M | $240.6M | -328.2K (-4.4%) | Trimmed |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.2M | $107.3M | — | New |
| 3 | DIMENSIONAL FUND ADVISORS LP | 2.5M | $81.8M | +137.8K (+6.0%) | Added |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 1.9M | $64.6M | — | New |
| 5 | Sumitomo Mitsui Trust Group, Inc. | 1.4M | $47.1M | +27.5K (+2.0%) | Added |
| 6 | Liontrust Investment Partners LLP | 440.1K | $19.9M | +0 (+0.0%) | No change |
| 7 | Boston Partners | 531.3K | $17.8M | +83.8K (+18.7%) | Added |
| 8 | Bank of New York Mellon Corp | 433.4K | $14.5M | +151.6K (+53.8%) | Added |
| 9 | Nuveen, LLC | 388.6K | $13.0M | -1.1K (-0.3%) | Trimmed |
| 10 | JPMORGAN CHASE & CO | 378.5K | $12.2M | -11.2K (-2.9%) | Trimmed |
| 11 | PRINCIPAL FINANCIAL GROUP INC | 296.3K | $9.9M | +26.4K (+9.8%) | Added |
| 12 | WCM INVESTMENT MANAGEMENT, LLC | 302.4K | $9.8M | — | New |
| 13 | VANGUARD FIDUCIARY TRUST CO | 288.0K | $9.6M | — | New |
| 14 | BURNEY CO/ | 213.2K | $7.1M | — | New |
| 15 | Invesco Ltd. | 199.0K | $6.6M | +2.8K (+1.4%) | Added |
| 16 | BANK OF MONTREAL /CAN/ | 179.3K | $6.0M | +8.8K (+5.2%) | Added |
| 17 | Public Sector Pension Investment Board | 160.6K | $5.4M | +5.2K (+3.3%) | Added |
| 18 | Legal & General Group Plc | 159.7K | $5.3M | -18.7K (-10.5%) | Trimmed |
| 19 | SEI INVESTMENTS CO | 148.4K | $5.0M | +25.9K (+21.1%) | Added |
| 20 | WELLS FARGO & COMPANY/MN | 140.0K | $4.7M | -38.6K (-21.6%) | Trimmed |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once OMCL's latest filing finishes processing.